Published in Am J Respir Crit Care Med on June 01, 2001
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. Thorax (2011) 2.84
PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model. Proc Natl Acad Sci U S A (2008) 2.22
Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial. Lancet Respir Med (2014) 1.96
In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study. BMC Med (2007) 1.82
Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin. J Clin Invest (2007) 1.73
Detection of cystic fibrosis transmembrane conductance regulator activity in early-phase clinical trials. Proc Am Thorac Soc (2007) 1.62
Cystic fibrosis lung disease: genetic influences, microbial interactions, and radiological assessment. Pediatr Radiol (2005) 1.48
Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model. J Mol Med (Berl) (2010) 1.40
Uptake of gentamicin by bullfrog saccular hair cells in vitro. J Assoc Res Otolaryngol (2003) 1.40
Cytoplasmic and intra-nuclear binding of gentamicin does not require endocytosis. Hear Res (2005) 1.37
New developments in aminoglycoside therapy and ototoxicity. Hear Res (2011) 1.35
Nonaminoglycoside compounds induce readthrough of nonsense mutations. J Exp Med (2009) 1.31
Ataluren as an agent for therapeutic nonsense suppression. Annu Rev Med (2012) 1.24
Therapeutics based on stop codon readthrough. Annu Rev Genomics Hum Genet (2014) 1.23
Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides. Nucleic Acids Res (2010) 1.17
Suppression of premature termination codons as a therapeutic approach. Crit Rev Biochem Mol Biol (2012) 1.13
Making sense of nonsense GABA(A) receptor mutations associated with genetic epilepsies. Trends Mol Med (2009) 1.13
Progress in cystic fibrosis and the CF Therapeutics Development Network. Thorax (2012) 1.12
Cystic fibrosis transmembrane conductance regulator protein repair as a therapeutic strategy in cystic fibrosis. Curr Opin Pulm Med (2010) 1.10
Restoration of W1282X CFTR activity by enhanced expression. Am J Respir Cell Mol Biol (2007) 1.10
Nonsense-mediated decay in genetic disease: friend or foe? Mutat Res Rev Mutat Res (2014) 1.10
Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor. Am J Respir Cell Mol Biol (2014) 1.10
No detectable improvements in cystic fibrosis transmembrane conductance regulator by nasal aminoglycosides in patients with cystic fibrosis with stop mutations. Am J Respir Cell Mol Biol (2007) 1.08
Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases. Wiley Interdiscip Rev RNA (2011) 1.08
In vitro and ex vivo suppression by aminoglycosides of PCDH15 nonsense mutations underlying type 1 Usher syndrome. Hum Genet (2007) 1.05
Influence of cystic fibrosis transmembrane conductance regulator on gene expression in response to Pseudomonas aeruginosa infection of human bronchial epithelial cells. Infect Immun (2005) 1.03
Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54. J Mol Med (Berl) (2011) 1.00
Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension. Am J Respir Cell Mol Biol (2013) 0.96
Nonsense suppressor therapies rescue peroxisome lipid metabolism and assembly in cells from patients with specific PEX gene mutations. J Cell Biochem (2011) 0.94
Adenosine regulation of cystic fibrosis transmembrane conductance regulator through prostenoids in airway epithelia. Am J Respir Cell Mol Biol (2006) 0.93
Mesh biocompatibility: effects of cellular inflammation and tissue remodelling. Langenbecks Arch Surg (2011) 0.93
A new series of small molecular weight compounds induce read through of all three types of nonsense mutations in the ATM gene. Mol Ther (2013) 0.92
Translational read-through of the RP2 Arg120stop mutation in patient iPSC-derived retinal pigment epithelium cells. Hum Mol Genet (2014) 0.92
Poly-L-aspartic acid enhances and prolongs gentamicin-mediated suppression of the CFTR-G542X mutation in a cystic fibrosis mouse model. J Biol Chem (2009) 0.90
Targets for cystic fibrosis therapy: proteomic analysis and correction of mutant cystic fibrosis transmembrane conductance regulator. Expert Rev Proteomics (2010) 0.89
Improved collagen type I/III ratio at the interface of gentamicin-supplemented polyvinylidenfluoride mesh materials. Langenbecks Arch Surg (2007) 0.89
Translational readthrough potential of natural termination codons in eucaryotes--The impact of RNA sequence. RNA Biol (2015) 0.88
Intracellular mechanisms of aminoglycoside-induced cytotoxicity. Integr Biol (Camb) (2011) 0.87
New and emerging targeted therapies for cystic fibrosis. BMJ (2016) 0.87
Optimizing nasal potential difference analysis for CFTR modulator development: assessment of ivacaftor in CF subjects with the G551D-CFTR mutation. PLoS One (2013) 0.83
Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations. Am J Respir Crit Care Med (2016) 0.82
Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients. Clin Microbiol Rev (2014) 0.79
CFTR: A New Horizon in the Pathomechanism and Treatment of Pancreatitis. Rev Physiol Biochem Pharmacol (2016) 0.78
Novel small molecules potentiate premature termination codon readthrough by aminoglycosides. Nucleic Acids Res (2016) 0.78
Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives. Clin Pharmacol (2016) 0.77
Moderate intensity exercise mediates comparable increases in exhaled chloride as albuterol in individuals with cystic fibrosis. Respir Med (2015) 0.77
Class 1 CF Mutations. Front Pharmacol (2012) 0.75
New therapeutic approaches for cystic fibrosis lung disease. J R Soc Med (2002) 0.75
Therapeutic benefit observed with the CFTR potentiator, ivacaftor, in a CF patient homozygous for the W1282X CFTR nonsense mutation. J Cyst Fibros (2016) 0.75
Nonsense Suppression as an Approach to Treat Lysosomal Storage Diseases. Diseases (2016) 0.75
Gentamicin B1 is a minor gentamicin component with major nonsense mutation suppression activity. Proc Natl Acad Sci U S A (2017) 0.75
Biomarkers for cystic fibrosis drug development. J Cyst Fibros (2016) 0.75
Small molecules as therapeutic agents for inborn errors of metabolism. J Inherit Metab Dis (2016) 0.75
Protecting adolescents from harm. Findings from the National Longitudinal Study on Adolescent Health. JAMA (1997) 26.02
Hybridization and speciation. J Evol Biol (2013) 14.24
Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev (2003) 10.43
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med (1999) 9.78
Decision aids for patients facing health treatment or screening decisions: systematic review. BMJ (1999) 9.70
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum (1996) 6.88
Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ (1999) 6.40
Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature (1999) 5.77
Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature (2001) 5.71
Asperger's syndrome: a clinical account. Psychol Med (1981) 5.46
5' untranslated sequences are required for the translational control of a yeast regulatory gene. Proc Natl Acad Sci U S A (1984) 5.42
Severe impairments of social interaction and associated abnormalities in children: epidemiology and classification. J Autism Dev Disord (1979) 5.40
Microstructural maturation of the human brain from childhood to adulthood. Neuroimage (2008) 5.30
ABFs, a family of ABA-responsive element binding factors. J Biol Chem (2000) 4.98
Twenty five years of case finding and audit in a socially deprived community. BMJ (1991) 4.89
Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04) J Clin Oncol (1999) 4.79
Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ (1999) 4.66
Coronary artery surgery: are women discriminated against? BMJ (1993) 4.52
The spc ribosomal protein operon of Escherichia coli: sequence and cotranscription of the ribosomal protein genes and a protein export gene. Nucleic Acids Res (1983) 4.46
Identification of an SCF ubiquitin-ligase complex required for auxin response in Arabidopsis thaliana. Genes Dev (1999) 4.35
The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol (1993) 4.09
Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera. J Cell Biol (1999) 4.06
Temporal analysis of general control of amino acid biosynthesis in Saccharomyces cerevisiae: role of positive regulatory genes in initiation and maintenance of mRNA derepression. Mol Cell Biol (1984) 3.97
Transcriptional repression by AtMYB4 controls production of UV-protecting sunscreens in Arabidopsis. EMBO J (2000) 3.97
Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations. Nat Med (1996) 3.82
Identification of AAS genes and their regulatory role in general control of amino acid biosynthesis in yeast. Proc Natl Acad Sci U S A (1983) 3.72
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess (2009) 3.67
HeartCare: an Internet-based information and support system for patient home recovery after coronary artery bypass graft (CABG) surgery. J Adv Nurs (2001) 3.36
The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res (2001) 3.30
Assessment of the reproducibility of clinical coding in routinely collected hospital activity data: a study in two hospitals. J Public Health Med (1998) 3.18
Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science (2000) 3.16
Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst (1988) 3.09
Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project. J Natl Cancer Inst (1999) 3.07
The efficiency of translation termination is determined by a synergistic interplay between upstream and downstream sequences in Saccharomyces cerevisiae. J Mol Biol (1995) 2.97
Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. N Engl J Med (1978) 2.95
Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02. J Clin Oncol (1990) 2.89
A molecular description of telometic heterochromatin in secale species. Cell (1980) 2.84
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet (2008) 2.81
Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin. J Am Acad Dermatol (2001) 2.80
A screening questionnaire for Asperger syndrome and other high-functioning autism spectrum disorders in school age children. J Autism Dev Disord (1999) 2.77
Telling the right patient. Br Med J (Clin Res Ed) (1981) 2.69
Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech Dev (2001) 2.69
Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med (1997) 2.67
Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev (2001) 2.65
Killing of Mycobacterium microti by immunologically activated macrophages. Nature (1981) 2.62
Bone-anchored hearing aids for people with bilateral hearing impairment: a systematic review. Clin Otolaryngol (2011) 2.58
Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res (1999) 2.54
Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children? Am J Psychiatry (1996) 2.54
Communicating information to patients: the use of cartoon illustrations to improve comprehension of instructions. Acad Emerg Med (1996) 2.52
Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy. Clin Infect Dis (2010) 2.51
Regulation of plasma membrane recycling by CFTR. Science (1992) 2.50
Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet (1995) 2.47
Tuberculosis infection among health care workers in Kampala, Uganda. Int J Tuberc Lung Dis (2005) 2.42
Improving care for patients with acute coronary syndromes: initial results from the National Audit of Myocardial Infarction Project (MINAP). Heart (2004) 2.38
A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome. Scand J Gastroenterol (2004) 2.37
A new Legionella species, Legionella feeleii species nova, causes Pontiac fever in an automobile plant. Ann Intern Med (1984) 2.35
Understanding men's health and illness: a gender-relations approach to policy, research, and practice. J Am Coll Health (2000) 2.34
Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system. RNA (2000) 2.31
Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line. Nat Med (1997) 2.24
Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II. J Biol Chem (1998) 2.24
Fluorescent labeling of recombinant proteins in living cells with FlAsH. Methods Enzymol (2000) 2.24
EGF stimulates lamellipod extension in metastatic mammary adenocarcinoma cells by an actin-dependent mechanism. Clin Exp Metastasis (1996) 2.16
Perfusion fMRI detects deficits in regional CBF during memory-encoding tasks in MCI subjects. Neurology (2007) 2.09
ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry (1997) 2.09
Guidelines for the use of fresh frozen plasma. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force. Transfus Med (1992) 2.07
Magnesium levels in cardiac arrest victims: relationship between magnesium levels and successful resuscitation. Ann Emerg Med (1987) 2.07
The impact of pre-hospital thrombolytic treatment on re-infarction rates: analysis of the Myocardial Infarction National Audit Project (MINAP). Heart (2007) 2.06
The secret life of the NHS. BMJ (2000) 2.04
Prohibitin, an evolutionarily conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells. Mol Cell Biol (1991) 2.04
Motor disorder in severe mental handicap. Br J Psychiatry (1991) 2.03
Wisconsin Card Sorting Test performance in patients with focal frontal and posterior brain damage: effects of lesion location and test structure on separable cognitive processes. Neuropsychologia (2000) 2.03
Delayed hemorrhage as a manifestation of occult vascular injury. Mil Med (1993) 2.03
Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia (2000) 2.02
Cranial gunshot wounds. J Am Osteopath Assoc (1990) 2.01
A prospective, randomized comparison of preoperative and continuous balanced epidural or paravertebral bupivacaine on post-thoracotomy pain, pulmonary function and stress responses. Br J Anaesth (1999) 2.00
Autism: not an extremely rare disorder. Acta Psychiatr Scand (1999) 1.99
The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression. Oncogene (2007) 1.97
Randomised controlled trial of effectiveness of Leicester hospital at home scheme compared with hospital care. BMJ (1999) 1.97
Suxamethonium in bunged cannulae. Anaesth Intensive Care (1991) 1.94
Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines. Cancer Res (1986) 1.94
Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review. Arthritis Rheum (1997) 1.92
Abuse of fresh frozen plasma. Br Med J (Clin Res Ed) (1987) 1.91
The handicaps of autistic children--a comparative study. J Child Psychol Psychiatry (1969) 1.90
Influence of flanking sequences on variability in expression levels of an introduced gene in transgenic tobacco plants. Nucleic Acids Res (1988) 1.89
Language, communication, and the use of symbols in normal and autistic children. J Autism Child Schizophr (1975) 1.88
The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling. J Exp Med (1998) 1.88
Life course impacts of parenting a child with a disability. Am J Ment Retard (2001) 1.87
Factor structure, reliability, and validity of the Pain Catastrophizing Scale. J Behav Med (1997) 1.87
Role of prostaglandin E1 and copper in angiogenesis. J Natl Cancer Inst (1982) 1.85
The paternal inheritance of the centrosome, the cell's microtubule-organizing center, in humans, and the implications for infertility. Nat Med (1995) 1.83
Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet (2006) 1.83
Screen detected high blood pressure under 40: a general practice population followed up for 21 years. BMJ (1993) 1.82
The kil gene of bacteriophage lambda. Virology (1975) 1.80
Effectiveness of an intervention promoting the female condom to patients at sexually transmitted disease clinics. Am J Public Health (2000) 1.80
Risk of mortality, cancer incidence, and stroke in a population potentially exposed to cadmium. Occup Environ Med (2000) 1.77